CA2021501A1 - Compose pharmaceutique a usage topique - Google Patents

Compose pharmaceutique a usage topique

Info

Publication number: CA2021501A1
Authority: CA; Canada
Prior art keywords: pharmaceutical compositions; topical pharmaceutical; prolonged; estradiol; corticosteroids
Prior art date: 1989-07-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA2021501A

Other languages

English (en)

Other versions

CA2021501C (fr

Inventor

Izhak Blank

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-21

Filing date

1990-07-19

Publication date

1991-01-22

1990-07-19 Application filed by Individual filed Critical Individual

1991-01-22 Publication of CA2021501A1 publication Critical patent/CA2021501A1/fr

2001-02-13 Application granted granted Critical

2001-02-13 Publication of CA2021501C publication Critical patent/CA2021501C/fr

2010-07-19 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000012049 topical pharmaceutical composition Substances 0.000 title 1
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 3
229960005309 estradiol Drugs 0.000 abstract 2
230000002035 prolonged effect Effects 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003246 corticosteroid Substances 0.000 abstract 1
229960001334 corticosteroids Drugs 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229930182833 estradiol Natural products 0.000 abstract 1
230000005012 migration Effects 0.000 abstract 1
238000013508 migration Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001766 physiological effect Effects 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

CA002021501A 1989-07-21 1990-07-19 Compose pharmaceutique a usage topique Expired - Fee Related CA2021501C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL91,067		1989-07-21
IL9106789A IL91067A (en)	1989-07-21	1989-07-21	Sustained-release transdermal pharmaceutical compositions comprising estrogens

Publications (2)

Publication Number	Publication Date
CA2021501A1 true CA2021501A1 (fr)	1991-01-22
CA2021501C CA2021501C (fr)	2001-02-13

Family

ID=11060200

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002021501A Expired - Fee Related CA2021501C (fr)	1989-07-21	1990-07-19	Compose pharmaceutique a usage topique

Country Status (8)

Country	Link
AU (1)	AU5908790A (fr)
CA (1)	CA2021501C (fr)
FI (1)	FI903653A7 (fr)
IE (1)	IE902573A1 (fr)
IL (1)	IL91067A (fr)
NO (1)	NO903257L (fr)
PT (1)	PT94787B (fr)
ZA (1)	ZA905671B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5474783A (en) *	1988-03-04	1995-12-12	Noven Pharmaceuticals, Inc.	Solubility parameter based drug delivery system and method for altering drug saturation concentration

1989
- 1989-07-21 IL IL9106789A patent/IL91067A/en not_active IP Right Cessation
1990
- 1990-07-13 IE IE257390A patent/IE902573A1/en unknown
- 1990-07-17 AU AU59087/90A patent/AU5908790A/en not_active Abandoned
- 1990-07-19 CA CA002021501A patent/CA2021501C/fr not_active Expired - Fee Related
- 1990-07-19 ZA ZA905671A patent/ZA905671B/xx unknown
- 1990-07-19 FI FI903653A patent/FI903653A7/fi not_active IP Right Cessation
- 1990-07-20 PT PT94787A patent/PT94787B/pt unknown
- 1990-07-20 NO NO90903257A patent/NO903257L/no unknown

Also Published As

Publication number	Publication date
IE902573A1 (en)	1991-02-27
AU5908790A (en)	1991-01-24
IL91067A0 (en)	1990-02-09
PT94787B (pt)	1997-04-30
NO903257L (no)	1991-01-22
FI903653A7 (fi)	1991-01-22
FI903653A0 (fi)	1990-07-19
NO903257D0 (no)	1990-07-20
ZA905671B (en)	1991-04-24
IL91067A (en)	1995-08-31
PT94787A (pt)	1991-03-20
CA2021501C (fr)	2001-02-13

Similar Documents

Publication	Publication Date	Title
CA2180816A1 (fr)	1997-01-12	6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
CA2193337A1 (fr)	1997-06-21	Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
HU892559D0 (en)	1990-01-28	Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
CA2068324A1 (fr)	1991-05-14	Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
IE790756L (en)	1979-10-11	Cerebral therapeutic agent
HUT61031A (en)	1992-11-30	Process for producing chemically modified, stable haemoglobin substituting for non-immunogehic red blood cell, and pharmaceutical compositions comprising same as active ingredient
CA2033725A1 (fr)	1991-07-25	Compositions pharmaceutiques et cosmetiques
CA2154424A1 (fr)	1996-01-24	1-phenyl-3-dimethylaminopropane possedant des proprietes pharmaceutiques
CA2148928A1 (fr)	1995-04-13	Derives pyridine pharmacologiquement actifs ainsi que leurs procedes de preparation
IE873125L (en)	1988-05-21	Benzimidazole derivatives
AU3091489A (en)	1989-09-07	Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
IL106562A0 (en)	1993-12-08	Pharmaceutical and/or cosmetic compositions and the use thereof
CA2254079A1 (fr)	1997-11-13	Derives de l'androstene
AU1890295A (en)	1995-09-25	Piperidines and pyrrolidines
EP0620004A4 (fr)	1995-02-01	Compositions medicinales.
CA2030962A1 (fr)	1991-05-29	Ameliorations en rapport avec l'administration d'agents pharmaceutiques
AU1950388A (en)	1989-01-19	Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
HUP9802897A3 (en)	2001-08-28	Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HU895241D0 (en)	1990-01-28	Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
AU1604592A (en)	1992-12-03	New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
HUT47124A (en)	1989-01-30	Process for producing pharmaceutical compositions comprising organic platinum complex as active ingredient and the active ingredients
AU4482489A (en)	1990-05-28	Novel tetrahydropyrimidine derivatives, process for their preparation and insecticides containing same as active ingredients
HUT54166A (en)	1991-01-28	Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
CA2021501A1 (fr)	1991-01-22	Compose pharmaceutique a usage topique
IE870577L (en)	1987-09-25	Topical amide preparation

Legal Events

Date	Code	Title	Description
1997-04-09	EEER	Examination request
2003-07-21	MKLA	Lapsed